Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Environ Res 151:493504
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
5 As comparison, 70/30 mixed insulin aspart was shown to have a mean increased weight of 4.04 kg
Zachary Crees, MD, an assistant professor of medicine at WashU Medicine, leads a clinical trial that is testing whether a new drug combination that includes DiPersios novel small molecule can enable more cells to be collected from the blood, potentially lessening the burden on patients to undergo multiple rounds of stem cell collection
US$ 21.78
US$ 27.33
US$ 29.35
US$ 22.93
US$ 23.02
US$ 25.23
US$ 24.66
